One patient received 5 covered stents which dislocated four times due to a very short stenotic tract and the effect of palliative chemotherapy with tumour necrosis. One other patient had a dislocation

of an uncovered stent in the proximal oesophagus and needed a new one. No case of perforation was seen. In nine cases (17%) (twice in one patient) clogging of the stent with food occurred. This was successfully solved by endoscopy. Tumour overgrowth was noted Inhibitors,research,lifescience,medical in four cases. No additional treatment was initiated in three cases because no important obstruction was noted; one patient needed a second stent. Twenty four LY2603618 patients (13 men, 11 women, mean age 68 years, range, 42-86 years) received 28 stents in their colon or rectum. One patient had a very long stenotic Inhibitors,research,lifescience,medical segment (due to ovarian cancer) and received two stent placed longitudinally in one procedure. The stents were placed in the rectum (n=6), the sigmoid (n=14), the descending colon (n=1), and the transverse colon (n=3). All patients had a dominant stenosis with obstruction. Mean survival after stent placement was 276 days (range, 3-1,131 days). Perforation occurred in zero cases. Tumour in-growth occurred in two patients. One patient received a second stent; in the other patient this was not possible anymore. This patient was treated with a surgical Inhibitors,research,lifescience,medical stoma. Dislocation occurred in two cases during placement. The stent was repositioned

Inhibitors,research,lifescience,medical in the same procedure. There were two cases of

clogging (8%) by stool. This was solved by endoscopic rinsing of the stool. Fourteen patients (5 men, 9 women, mean age 76 years, range, 37-92 years) received 18 stents because of obstructing stomach cancer. This was because of nine distal cancers and four cancer located in the gastric cardia. The latter received covered expandable stents, the remainder uncovered stents. There was Inhibitors,research,lifescience,medical one case of cancer in a Billroth II resection stomach. Mean survival after stent placement was 121 days (range, 30-335 days). There was no perforation, one case of clogging, and four cases of tumour ingrowth. Two patients got three stents each because of ingrowth. Two of them received no additional treatment. Their survival was 189 and 332 days respectively after placement of the first stent. Eight patients (4 men, 4 women, mean age 63 years, range, 40-83 years) had stent placement in their duodenum. This was because of ingrowing pancreatic cancer in two cases, cancer of the distal bile duct in two, and obstructing duodenal cancer in four patients. already Mean survival after stent placement was 84 days (range, 9-223 days). No perforation or clogging occurred. Three cases of tumour ingrowth were seen. The tumour ingrowth did not lead to significant new obstruction. In addition, five patients got an oesophageal stent because of stenosis due to ingrowing bronchial cancer; one patient had stenosis in the course of breast cancer (3 men, 3 women, mean age 71 years, range, 57-86 years).